双相障碍、精神分裂症与孤独症谱系障碍的基因与调控拷贝数变异跨诊断分析
该研究基于8708例日本样本的高分辨率拷贝数变异(CNV)数据,跨诊断分析双相障碍(BD)、精神分裂症(SCZ)与孤独症谱系障碍(ASD)中基因与调控CNV的异同。结果显示BD与SCZ/ASD在CNV负荷、神经发育障碍相关CNV特征及调控CNV上存在差异,但共享包括染色质生物学在内的分子机制,并识别出DLG2、PCDH15和ASTN2三个BD风险基因。
要点
- BD中小于100 kb的外显子缺失负荷增加,SCZ/ASD中大于500 kb的外显子CNV负荷最高。
- 神经发育障碍相关致病CNV与三种疾病风险均显著关联,但BD效应量较小且亚型分布不同。
- SCZ和ASD中CNV显著富集于脑组织增强子和启动子,BD中未观察到该富集。
核心结论
- BD与SCZ/ASD在CNV负荷、神经发育障碍相关CNV特征及调控CNV上存在差异。
- BD与SCZ/ASD共享分子机制,包括染色质生物学。
- 研究识别的BD风险基因可为BD发病机制提供线索。
研究设计与样本
- 基于8708例日本样本的高分辨率CNV数据,进行BD、SCZ和ASD的基因与调控CNV跨诊断分析。
主要发现
- BD中小于100 kb的外显子缺失负荷增加,SCZ/ASD中大于500 kb的外显子CNV负荷最高。
- 神经发育障碍相关致病CNV与每种疾病风险显著关联,但BD与SCZ/ASD在效应量(BD较小)和亚型分布上不同。
- 识别出DLG2、PCDH15和ASTN2三个突触基因作为BD风险因素。
- 基因集分析显示BD相关通路限于染色质生物学,SCZ和ASD涉及更广泛且相似的通路。
- 基因集结果相关分析显示BD与SCZ或ASD间通路相似性弱但显著(r = 0.25–0.31)。
关键数值与推荐
- BD中小于100 kb的外显子缺失负荷增加,SCZ/ASD中大于500 kb的外显子CNV负荷最高。
- BD与SCZ或ASD基因集结果相关分析的r = 0.25–0.31。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to determine the similarities and differences in the roles of genic and regulatory copy number variations (CNVs) in bipolar disorder (BD), schizophrenia (SCZ), and autism spectrum disorder (ASD). METHODS: Based on high-resolution CNV data from 8708 Japanese samples, we performed to our knowledge the largest cross-disorder analysis of genic and regulatory CNVs in BD, SCZ, and ASD. RESULTS: In genic CNVs, we found an increased burden of smaller (<100 kb) exonic deletions in BD, which contrasted with the highest burden of larger (>500 kb) exonic CNVs in SCZ/ASD. Pathogenic CNVs linked to neurodevelopmental disorders were significantly associated with the risk for each disorder, but BD and SCZ/ASD differed in terms of the effect size (smaller in BD) and subtype distribution of CNVs linked to neurodevelopmental disorders. We identified 3 synaptic genes (DLG2, PCDH15, and ASTN2) as risk factors for BD. Whereas gene set analysis showed that BD-associated pathways were restricted to chromatin biology, SCZ and ASD involved more extensive and similar pathways. Nevertheless, a correlation analysis of gene set results indicated weak but significant pathway similarities between BD and SCZ or ASD (r = 0.25-0.31). In SCZ and ASD, but not BD, CNVs were significantly enriched in enhancers and promoters in brain tissue. CONCLUSIONS: BD and SCZ/ASD differ in terms of CNV burden, characteristics of CNVs linked to neurodevelopmental disorders, and regulatory CNVs. On the other hand, they have shared molecular mechanisms, including chromatin biology. The BD risk genes identified here could provide insight into the pathogenesis of BD.
引用
- Kushima I, Nakatochi M, Aleksic B, et al. Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder. Biol Psychiatry. 2022. PMID: 35667888. doi:10.1016/j.biopsych.2022.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。